Description
A TPH1 inhibitor (IC50 = 16 nM); dietary administration to pregnant and lactating mice decreases 5-HT levels in maternal serum and decreases the femoral bone volume to tissue volume ratio, trabecular number and thickness, and cortical tissue mineral density, as well as serum calcium levels, in pups
Formal name: 4-[2-amino-6-[(1R)-1-[4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]-4-pyrimidinyl]-L-phenylalanine
Synonyms: LP778902
Molecular weight: 546.9
CAS: 1033805-28-5
Purity: ≥98%
Formulation: A crystalline solid